GVBL closed at ₹29.88 on Sep 4, 2026. GENOMIC VALLEY BIOTECH LIMITED (GVBL) trades on BSE. Market capitalisation is ₹9.13 Cr. The trailing P/E ratio is 498.00. It operates in the Healthcare sector.
GVBL, Upmazing Score 26/100
GENOMIC VALLEY BIOTECH LIMITED (BSE: GVBL) scores 26 on Upmazing’s scoring engine, graded on one layer so far: fundamentals filed with the exchange — the technical layer isn’t gradeable yet and is not part of this number. Below: each signal layer and the numbers behind it, marked with their sources.
Not built yetAI synthesis — not built yetOne paragraph that fuses GVBL's latest filings with its price structure. Not built yet — nothing behind this card generates it today.
Genomic Valley Biotech Ltd - 539206 - Intimation Of Approval Of Extension Of Time For Holding Annual General Meeting (AGM) Of The Company For The Financial Year Ended On 31St March 2026, Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Aug 31, 2026 · BSE · raw filing ↗
Filing
Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 17, 2026 · BSE · raw filing ↗
About & managementfrom filings & exchange disclosures
GENOMIC VALLEY BIOTECH LIMITED is a micro-cap healthcare company traded on the BSE.
Coming soon
Company facts (founded, HQ, employees) and the board / KMP roster with tenures arrive with the company-profile source.
GVBL doesn't have 5Y of listed history yet — the calculator unlocks as price history accrues.
Past EOD returns redistributed — not a projection. LTCG shown at 12.5% beyond the ₹1.25 L/yr exemption (FY26 rules), indicative only, not tax advice; SIP units have mixed holding periods.
Frequently asked
auto-built per stock · FAQ schema
Once GVBL's end-of-day history is ingested, this page shows its official exchange close, refreshed after each trading session, with the full price history on the Chart tab (split- and bonus-adjusted for NSE-primary series; BSE-primary series are shown as-traded). Upmazing does not stream live quotes, so every price-linked figure is anchored to the last close.
Where enough filed data exists, GVBL carries an Upmazing Score, a 0-100 standing computed from its real fundamentals (growth, margins, leverage, returns) and end-of-day technicals. The Score tab breaks down every component, and says plainly when one can't be computed.
After each session with price data on record, GVBL runs through Upmazing's end-of-day scanner library, covering momentum, trend, volatility, volume and fundamental checks. Scanners that fired on the latest session are listed on the Patterns tab with the exact rule each fired on.
Declared dividends, ex-dates and bonus or split history for GVBL come from corporate-action records and appear here as they are ingested. Dividend yield is computed on trailing-12-month dividends at the last close.
Comparable companies for GVBL are grouped by sector, then compared on revenue growth, ROE, ROCE, debt-to-equity and margins. The Peers tab shows the full side-by-side table, and where a sector is classified, the sector peers panel on this page links the largest sector-mates.
Market cap for GVBL is computed from shares outstanding in the filed balance sheet, priced at the last close, and refreshed after each session. Where the balance-sheet input or a last close is missing, the cell shows a dash rather than an estimate.
The trailing 52-week high and low for GVBL are derived from its end-of-day price history and appear in the key statistics on this page once a full year of sessions is on record. The full price chart lives on the Chart tab.
The filed balance sheet for GVBL is presented on the Financials tab; for non-lenders that includes debt-to-equity, while banks and NBFCs read leverage through banking ratios instead.
Where GVBL's shareholding pattern has been ingested, the Holdings tab tracks promoter, FII, mutual-fund, DII and public holding plus any promoter pledge, quarter by quarter from the disclosed filings.
Prices are official exchange end-of-day closes, refreshed after each trading session. Fundamentals, shareholding and corporate actions for GVBL are parsed from official filings — quarterly results, shareholding disclosures and corporate-action records — as they are published.
Filed results · standalone·as of Q1 2026-27partial data
Frequently Asked Questions
What is GENOMIC VALLEY BIOTECH LIMITED's share price today?
GENOMIC VALLEY BIOTECH LIMITED (GVBL) closed at ₹29.88 on 2026-09-04.
Which sector does GENOMIC VALLEY BIOTECH LIMITED belong to?
GENOMIC VALLEY BIOTECH LIMITED is classified under sector 'Healthcare' / industry 'Biotechnology' per NSE's 4-tier classification.
What is GENOMIC VALLEY BIOTECH LIMITED's PE ratio?
GENOMIC VALLEY BIOTECH LIMITED's trailing PE ratio is 498.0x based on the latest filed earnings and market close.
